Most cited papers from GenomiCare (China)

GenomiCare (China)

What are the most cited papers from GenomiCare (China)?

The most cited paper from GenomiCare (China) is "Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR–STAT3 signalling" (Xinya Gao, Xin Xia, Fanying Li et al., 2021), with 436 citations. Next come "Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer" (65) and "Two cases of intrahepatic cholangiocellular carcinoma with high insertion-deletion ratios that achieved a complete response following chemotherapy combined with PD-1 blockade" (50).

Published TypeFieldAccess

Showing 50 of 51 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR–STAT3 signalling Xinya Gao, Xin Xia, Fanying Li et al. · Nature Cell Biology	Mar 2021	436
2	Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer Yuan‐Sheng Zang, Chun Dai, Xiaoman Xu et al. · Cancer Medicine Open access	4 Jul 2019	65
3	Two cases of intrahepatic cholangiocellular carcinoma with high insertion-deletion ratios that achieved a complete response following chemotherapy combined with PD-1 blockade Minghao Sui, Yu Li, Hongguang Wang et al. · Journal for ImmunoTherapy of Cancer Open access	7 May 2019	50
4	Clinical and Molecular Characteristics of Thalamic Gliomas: Retrospective Report of 26 Cases Yikui Liu, Yi Zhang, Wei Hua et al. · World Neurosurgery	16 Mar 2019	46
5	Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors Jiaping Li, Wei Jiang, Jinwang Wei et al. · Journal of Translational Medicine Open access	Aug 2020	40
6	Activity of PD-1 Inhibitor Combined With Anti-Angiogenic Therapy in Advanced Sarcoma: A Single-Center Retrospective Analysis Yang You, Xi Guo, Rongyuan Zhuang et al. · Frontiers in Molecular Biosciences Open access	16 Nov 2021	35
7	Genetic Examination for Fetuses with Increased Fetal Nuchal Translucency by Genomic Technology Shuya Xue, Huanchen Yan, Jingsi Chen et al. · Cytogenetic and Genome Research	2020	35
8	Distinct microbes, metabolites, and the host genome define the multi-omics profiles in right-sided and left-sided colon cancer Liang Lei, Cheng Kong, Jinming Li et al. · Microbiome Open access	27 Dec 2024	34
9	Rapid tumor regression in an Asian lung cancer patient following personalized neo-epitope peptide vaccination Fenge Li, Caixia Chen, Tao Ju et al. · OncoImmunology Open access	7 Oct 2016	31
10	Comprehensive analysis of age‐related somatic mutation profiles in Chinese young lung adenocarcinoma patients Bo Yeun Yang, Jie Li, Fang Li et al. · Cancer Medicine Open access	Mar 2019	23
11	Comprehensive multi‐omics analysis of resectable locally advanced gastric cancer: Assessing response to neoadjuvant camrelizumab and chemotherapy in a single‐center, open‐label, single‐arm phase II trial Yuzhou Zhao et al. · Clinical and Translational Medicine Open access	29 Apr 2024	22
12	Estimating tumor mutational burden across multiple cancer types using whole-exome sequencing Chuang Zhou, Chen Song, Fei Xu et al. · Annals of Translational Medicine Open access	Sep 2021	21
13	Comprehensive analysis of potential immunotherapy genomic biomarkers in 1,000 Chinese patients with cancer Shunchang Jiao, Yuan‐Sheng Zang, Chun Dai et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access	10 Jul 2018	21
14	Serial circulating tumor DNA profiling predicts tumor recurrence after liver transplantation for liver cancer Ao Huang, De‐Zhen Guo, Xuan Zhang et al. · Hepatology International	18 Nov 2023	20
15	Integrated genomic and transcriptomic analysis suggests KRT18 mutation and MTAP are key genetic alterations related to the prognosis between astrocytoma and glioblastoma Zhiyong Li, Yinghui Jin, Qingping Zou et al. · Annals of Translational Medicine Open access	Apr 2021	18
16	Integrated genomic and transcriptomic analysis revealed mutation patterns of de-differentiated liposarcoma and leiomyosarcoma Wenshuai Liu, Hanxing Tong, Chenlu Zhang et al. · BMC Cancer Open access	28 Oct 2020	18
17	Xenograft tumors derived from malignant pleural effusion of the patients with non‐small‐cell lung cancer as models to explore drug resistance Yunhua Xu, Feifei Zhang, Xiaoqing Q. Pan et al. · 癌症：英文版 Open access	8 May 2018	18
18	A stop-gain mutation in GXYLT1 promotes metastasis of colorectal cancer via the MAPK pathway Lin Peng, Min Zhao, Tianqi Liu et al. · Cell Death and Disease Open access	22 Apr 2022	17
19	Whole-exome sequencing identifies prognostic mutational signatures in gastric cancer Zhenxin Zhu, Hongbing Fu, Shengzhou Wang et al. · Annals of Translational Medicine Open access	Nov 2020	16
20	Efficacy and Resistance of ALK Inhibitors in Two Inflammatory Myofibroblastic Tumor Patients with ALK Fusions Assessed by Whole Exome and RNA Sequencing Chenlu Zhang, Zhiming Wang, Rongyuan Zhuang et al. · OncoTargets and Therapy Open access	Oct 2020	15
21	Comprehensive molecular characterization of long-term glioblastoma survivors Hao Xu, Xinyu Chen, Ying Sun et al. · Cancer Letters Open access	10 May 2024	14
22	Pleomorphic xanthoastrocytoma, anaplastic pleomorphic xanthoastrocytoma, and epithelioid glioblastoma: Case series with clinical characteristics, molecular features and progression relationship Zhiying Lin, Runwei Yang, Haojie Zheng et al. · Clinical Neurology and Neurosurgery Open access	20 Jul 2022	14
23	Unique genomic features and prognostic value of COSMIC mutational signature 4 in lung adenocarcinoma and lung squamous cell carcinoma Xiuyu Cai, Zhenghe Chen, Meiling Deng et al. · Annals of Translational Medicine Open access	Sep 2020	11
24	Germline ALK variations are associated with a poor prognosis in glioma and IDH-wildtype glioblastoma Linghao Bu, N. U. Farrukh Hameed, Chen Luo et al. · Journal of Neuro-Oncology	24 Jan 2021	10
25	Whole-exome sequencing identifies a set of genes as markers of hepatocellular carcinoma early recurrence Huizhong Shi, Wenwen Zhang, Bingyang Hu et al. · Hepatology International	23 Dec 2022	9
26	Integrative genomic analysis of drug resistance in MET exon 14 skipping lung cancer using patient-derived xenograft models Yunhua Xu, Linping Gu, Yingqi Li et al. · Frontiers in Oncology Open access	21 Oct 2022	9
27	An open, observational, three-arm clinical study of 2–3 cycles of treatment as neoadjuvant therapy in operable locally advanced non-small cell lung cancer: An interim analysis Linping Gu, Xue Chao Wang, Yile Sun et al. · Frontiers in Immunology Open access	19 Aug 2022	7
28	Integrative Genomic and Transcriptomic Analysis of Primary Malignant Gliomas Revealed Different Patterns Between Grades and Somatic Mutations Related to Glioblastoma Prognosis Huawei Jin, Zhenhua Yu, Tian Tian et al. · Frontiers in Molecular Biosciences Open access	5 Jul 2022	7
29	Development of a genome atlas for discriminating benign, preinvasive, and invasive lung nodules Peng Liang, Minhua Peng, Jinsheng Tao et al. · MedComm Open access	19 Jul 2024	6
30	Exploration of the immunogenetic landscape of hyperprogressive disease after combined immunotherapy in cancer patients Caifeng Gong, Wen Zhang, Yongkun Sun et al. · iScience Open access	22 Apr 2023	5
31	Using Clinical Genomic Sequencing to Guide Personalized Cancer Therapy in China Yuxian Bai, Guan Wang, Jinwang Wei et al. · Personalized Medicine	21 Mar 2019	5
32	Identification of a novel KCNT2 variant in a family with developmental and epileptic encephalopathies: a case report and literature review Fengji Cui, Tuoya Wulan, Qian Zhang et al. · Frontiers in Genetics Open access	6 Mar 2024	4
33	Genomic characterization of intracranial teratomas using whole genome sequencing Chao Zhang, Xiaoyu Zhou, Xiang Huang et al. · Frontiers in Oncology Open access	15 Nov 2022	4
34	Rosai-Dorfman disease in the central nervous system with two isolated lesions originated from a single clone: a case report Huawei Jin, Zhenhua Yu, Tian Tian et al. · BMC Neurology Open access	13 Sep 2021	4
35	Predictive Biomarkers of Dicycloplatin Resistance or Susceptibility in Prostate Cancer Minglu Liu, Xiaoyu Zhou, Jun Liu et al. · Frontiers in Genetics Open access	27 Jul 2021	4
36	Genomic landscape and molecular subtypes of primary central nervous system lymphoma Shengjie Li, Danhui Li, Zuguang Xia et al. · Blood Cancer Journal Open access	26 Nov 2025	2
37	Whole‐exome sequencing has revealed novel genetic characteristics in intracranial germ cell tumours in the Chinese Xiang Huang, Jianhan Huang, Xiaoyu Zhou et al. · Histopathology	26 Feb 2024	2
38	Comprehensive molecular characterization of adult H3K27M mutated thalamic glioma long-term survivors Hao Xu, Xiaomu Hu, Biyun Wang et al. · Experimental Hematology and Oncology Open access	13 Jun 2025	1
39	Genomic Landscape and Molecular Subtypes of Primary Central Nervous System Lymphoma Shujing Li, Danhui Li, Zuguang Xia et al. · medRxiv PreprintOpen access	23 Oct 2024	1
40	Exploring the Burden on Patients Living With and Receiving Treatment for Immune Thrombocytopenia ( ITP ): Patient and Physician Perceptions From the ITP World Impact Survey (I‐ WISh ) 2.0 Nichola Cooper, James Bussel, W G Ghanima et al. · American Journal of Hematology Open access	3 Jun 2026	0
41	WHOLE GENOME AND TRANSCRIPTOME SEQUENCING OF EMBRYOS IDENTIFIES POTENTIAL CAUSE OF RECURRENT PREGNANCY LOSS: A CLINICAL CASE STUDY Andrea Djolovic, Breanne Dale, Kaylene J. Ready et al. · Fertility and Sterility	Dec 2025	0
42	Heterogenous driving genetic events contribute to the dissemination of choroid plexus papilloma Yuan Feng, Hao Xu, Xiaomu Hu et al. · Journal of Neuropathology & Experimental Neurology Open access	21 Nov 2023	0
43	whole-exome sequencing identifies a set of genes as markers of early hepatocellular carcinoma recurrence Shichun Lu, Huizhong Shi, Wenwen Zhang et al. · Research Square PreprintOpen access	22 Sep 2022	0
44	Biomarcadores asociados con scrapie y otras encefalopatías espongiformes transmisibles Rosa Bolea, Hicham Filali, Inmaculada Martín‐Burriel et al. · Informacion Tecnica Economica Agraria Open access	Mar 2014	0
45	Is the ACADVL c.1226C>T (p.T409M) Variant a Mutation from the Pacific Islands? A Hawaiian Newborn Screening Dried Bloodspots Study Nathaniel Barasa, Kejian Zhang, Victor Wei Zhang et al. · Genetics & Molecular Medicine Open access	30 Dec 2021	0
46	Prognostic and Predictive Value of Circulating Tumor DNA in Patients with Advanced Colorectal Cancer and Chemotherapy Xiu Liu, Yibin Xie, Kai Ou et al. · Research Square PreprintOpen access	15 Jun 2021	0
47	Integrated genomic and transcriptomic analysis revealed mutagenic patterns of dedifferentiated liposarcoma and leiomyosarcoma in Chinese patients Yi Zhou, Wei Lu, Y. Zhang et al. · Annals of Oncology Open access	Nov 2019	0
48	Whole-Exome Sequencing Identified Multiple Germline Mutations of DNA Repair Pathway in Patients with and without a Family History of Nasopharyngeal Carcinoma Xiaomin Ou, G. Wang, Chunying Shen et al. · International Journal of Radiation OncologyBiologyPhysics	Sep 2019	0
49	Individualized ctDNA Fingerprints to Monitor Treatment Response and Recurrence in Multiple Cancer Types Jiaping Li, Wei Jiang, Jinwang Wei et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access	12 Aug 2019	0
50	P2.04-19 Correlation of Clinicopathological Characteristics with Tumor Mutation Burden in Chinese Patients with NSCLC Shun Lu, Yan Yu, G. Wang et al. · Journal of Thoracic Oncology Open access	Oct 2018	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.